222 related articles for article (PubMed ID: 22846092)
1. Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma.
Alqawlaq S; Huzil JT; Ivanova MV; Foldvari M
Nanomedicine (Lond); 2012 Jul; 7(7):1067-83. PubMed ID: 22846092
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
[TBL] [Abstract][Full Text] [Related]
3. The Pathway From Genes to Gene Therapy in Glaucoma: A Review of Possibilities for Using Genes as Glaucoma Drugs.
Borrás T
Asia Pac J Ophthalmol (Phila); 2017; 6(1):80-93. PubMed ID: 28161916
[TBL] [Abstract][Full Text] [Related]
4. Preclinical development and ocular biodistribution of gemini-DNA nanoparticles after intravitreal and topical administration: towards non-invasive glaucoma gene therapy.
Alqawlaq S; Sivak JM; Huzil JT; Ivanova MV; Flanagan JG; Beazely MA; Foldvari M
Nanomedicine; 2014 Nov; 10(8):1637-47. PubMed ID: 24905400
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma.
Zhang K; Zhang L; Weinreb RN
Nat Rev Drug Discov; 2012 Jun; 11(7):541-59. PubMed ID: 22699774
[TBL] [Abstract][Full Text] [Related]
6. Small interfering RNAs (siRNAs) based gene silencing strategies for the treatment of glaucoma: Recent advancements and future perspectives.
Naik S; Shreya AB; Raychaudhuri R; Pandey A; Lewis SA; Hazarika M; Bhandary SV; Rao BSS; Mutalik S
Life Sci; 2021 Jan; 264():118712. PubMed ID: 33159955
[TBL] [Abstract][Full Text] [Related]
7. Ocular gene delivery using lentiviral vectors.
Balaggan KS; Ali RR
Gene Ther; 2012 Feb; 19(2):145-53. PubMed ID: 22052240
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for optic nerve disease.
Martin KR; Quigley HA
Eye (Lond); 2004 Nov; 18(11):1049-55. PubMed ID: 15534589
[TBL] [Abstract][Full Text] [Related]
9. Dendrimers for gene delivery--a potential approach for ocular therapy?
Chaplot SP; Rupenthal ID
J Pharm Pharmacol; 2014 Apr; 66(4):542-56. PubMed ID: 24635556
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in ocular drug delivery.
Chen H
J Drug Target; 2015; 23(7-8):597-604. PubMed ID: 26453157
[TBL] [Abstract][Full Text] [Related]
11. Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems.
Juliana FR; Kesse S; Boakye-Yiadom KO; Veroniaina H; Wang H; Sun M
Molecules; 2019 Oct; 24(20):. PubMed ID: 31652593
[TBL] [Abstract][Full Text] [Related]
12. Potential Therapeutic Usage of Nanomedicine for Glaucoma Treatment.
Kwon S; Kim SH; Khang D; Lee JY
Int J Nanomedicine; 2020; 15():5745-5765. PubMed ID: 32821099
[TBL] [Abstract][Full Text] [Related]
13. Ophthalmic drug discovery.
Clark AF; Yorio T
Nat Rev Drug Discov; 2003 Jun; 2(6):448-59. PubMed ID: 12776220
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine for the treatment of retinal and optic nerve diseases.
Zarbin MA; Montemagno C; Leary JF; Ritch R
Curr Opin Pharmacol; 2013 Feb; 13(1):134-48. PubMed ID: 23142104
[TBL] [Abstract][Full Text] [Related]
15. Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma.
Zhou Y; Pernet V; Hauswirth WW; Di Polo A
Mol Ther; 2005 Sep; 12(3):402-12. PubMed ID: 15975850
[TBL] [Abstract][Full Text] [Related]
16. Applications of nanoparticles in ophthalmology.
Diebold Y; Calonge M
Prog Retin Eye Res; 2010 Nov; 29(6):596-609. PubMed ID: 20826225
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy for retinal ganglion cell neuroprotection in glaucoma.
Wilson AM; Di Polo A
Gene Ther; 2012 Feb; 19(2):127-36. PubMed ID: 21975466
[TBL] [Abstract][Full Text] [Related]
18. Molecular and cell-based approaches for neuroprotection in glaucoma.
Lebrun-Julien F; Di Polo A
Optom Vis Sci; 2008 Jun; 85(6):417-24. PubMed ID: 18521011
[TBL] [Abstract][Full Text] [Related]
19. Ocular Drug Delivery: Present Innovations and Future Challenges.
Gote V; Sikder S; Sicotte J; Pal D
J Pharmacol Exp Ther; 2019 Sep; 370(3):602-624. PubMed ID: 31072813
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnology in ocular drug delivery.
Sahoo SK; Dilnawaz F; Krishnakumar S
Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
